$600M senior secured credit agreement with JPMorgan Chase, Morgan Stanley, Goldman Sachs, and TD Securities
Company: Core Scientific
The claim, verbatim
Core Scientific entered into a senior secured credit agreement with JPMorgan Chase, Morgan Stanley, Goldman Sachs, and TD Securities, providing a $100 million revolving credit facility and $500 million letter-of-credit facility, guaranteed by key domestic subsidiaries and secured by first-priority liens on substantially all assets, with quarterly liquidity requirements of at least $150 million and minimum market capitalization of $3 billion before each revolving draw.
Source (primary)
Core Scientific Secures New $600 Million Credit Facilities - The Globe and Mail (-, news_article)
View cached copy (2026-09-02)Live source ↗Archive.org ↗
Quote: “On August 25, 2026, Core Scientific Inc. entered into a senior secured credit agreement establishing a $100 million revolving credit facility and a $500 million letter-of-credit facility with a syndicate led by JPMorgan Chase, Morgan Stanley, Goldman Sachs and TD Securities. The facilities, which were announced on August 27, 2026, are guaranteed by key domestic subsidiaries, secured by first-priority liens on substantially all assets and come with liquidity and market-capitalization tests alongside customary covenants on leverage, dividends and corporate transactions.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific Secures New $600 Million Credit Facilities - The Globe and Mail
Quote: “On August 25, 2026, Core Scientific Inc. entered into a senior secured credit agreement establishing a $100 million revolving credit facility and a $500 million letter-of-credit facility with a syndicate led by JPMorgan Chase, Morgan Stanley, Goldman Sachs and TD Securities. The facilities, which were announced on August 27, 2026, are guaranteed by key domestic subsidiaries, secured by first-priority liens on substantially all assets and come with liquidity and market-capitalization tests alongside customary covenants on leverage, dividends and corporate transactions.”